International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Aug 11, 2017, after the close
10-Q filed Aug 11, 2017, 42 days after period end · 0001564590-17-017427
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $1.76M | $1.92M | $1.82M | $1.59M |
| Net Income | $568.00K | $10.92M | $723.00K | -$4.41M |
| EPS Diluted | -$0.25 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| $0.26 |
| -$0.52 |
| -$3.88 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
